Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase I/II study of MG1109 pre-pandemic influenza (H5N1) vaccine
KCT0000119Phase 2Recruiting
- Sponsor
- GC Biopharma
- Start
- Feb 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of MG1109 in avian influenza (HPAI), sponsored by GC Biopharma. Started Feb 2010; status: recruiting.
02
Drugs
MG1109
03
Conditions
avian influenza (HPAI)
Beyond the preview
Go deeper on KCT0000119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000119.